Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 24,539 | 28,085 | 28,420 | 19,830 | 18,422 |
| Gross Profit | 24,190 | 28,290 | 28,420 | 19,470 | 19,310 |
| Operating Expenses | 27,320 | 23,130 | 29,780 | 24,050 | 25,770 |
| Operating Income | -2,781 | 4,955 | -1,360 | -4,220 | -7,348 |
| Other Income | -1,349 | 185 | -1,690 | -3,570 | 8,838 |
| Pre-tax Income | -4,130 | 5,140 | -3,050 | -7,790 | 1,490 |
| Income Tax | 300 | -210 | -430 | -290 | 120 |
| Net Income Continuous | -4,503 | 5,324 | -2,600 | -7,640 | 1,311 |
| Net Income Discontinuous | 0 | 7,419 | -59,620 | -1,900 | -1,655 |
| Net Income | $-4,503 | $12,743 | $-62,230 | $-9,540 | $-344 |
| EPS Basic Total Ops | -0.09 | 0.25 | N/A | -0.21 | -0.01 |
| EPS Basic Continuous Ops | -0.09 | 0.10 | N/A | -0.17 | 0.03 |
| EPS Basic Discontinuous Ops | N/A | 0.14 | N/A | -0.04 | -0.04 |
| EPS Diluted Total Ops | -0.09 | 0.25 | N/A | -0.21 | -0.01 |
| EPS Diluted Continuous Ops | -0.09 | 0.10 | N/A | -0.17 | 0.03 |
| EPS Diluted Discontinuous Ops | N/A | 0.14 | N/A | -0.04 | -0.04 |
| EBITDA(a) | $-2,781 | $4,955 | $-3,360 | $-4,220 | $-7,348 |